These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29590513)

  • 1. Genome "Surgery"?
    Klein M
    Hastings Cent Rep; 2018 Mar; 48(2):inside front cover. PubMed ID: 29590513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR: express delivery to any DNA address.
    Peterson A
    Oral Dis; 2017 Jan; 23(1):5-11. PubMed ID: 27040868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The commercialization of genome-editing technologies.
    Brinegar K; K Yetisen A; Choi S; Vallillo E; Ruiz-Esparza GU; Prabhakar AM; Khademhosseini A; Yun SH
    Crit Rev Biotechnol; 2017 Nov; 37(7):924-932. PubMed ID: 28100080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starting the conversation: CRISPR's role in India.
    Udwadia F; Singh S
    Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticipating Emerging Biotechnology Threats:
    Vogel KM; Ouagrham-Gormley SB
    Politics Life Sci; 2018 Dec; 37(2):203-219. PubMed ID: 31120699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
    Zaidi SS; Mahfouz MM; Mansoor S
    Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Scientists Perceive CRISPR's Translational Promise and the Implications for Individuals with Genetic Conditions.
    Halpern J; O'Hara SE; Owen AL; Paolo D
    Ethics Hum Res; 2021 Nov; 43(6):28-41. PubMed ID: 34751516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Playing God? Media coverage of CRISPR in the United States.
    Stapleton P; Torres Yabar A
    Public Underst Sci; 2023 May; 32(4):504-521. PubMed ID: 36527362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genome editing ~Principle and possibility of a novel genetic engineering technology. Basic principles of genome editing.].
    Yamamoto T
    Clin Calcium; 2017; 27(11):1638-1644. PubMed ID: 29074838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New variants of CRISPR RNA-guided genome editing enzymes.
    Murovec J; Pirc Ž; Yang B
    Plant Biotechnol J; 2017 Aug; 15(8):917-926. PubMed ID: 28371222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basics and applications of genome editing technology].
    Yamamoto T; Sakamoto N
    Rinsho Ketsueki; 2016; 57(10):1869-1873. PubMed ID: 27725582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise and peril of CRISPR gene drives: Genetic variation and inbreeding may impede the propagation of gene drives based on the CRISPR genome editing technology.
    Zentner GE; Wade MJ
    Bioessays; 2017 Oct; 39(10):. PubMed ID: 28863233
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Miccio A; Porteus M
    CRISPR J; 2021 Jun; 4(3):303. PubMed ID: 34152212
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPR-Cas9 technology: applications and human disease modelling.
    Torres-Ruiz R; Rodriguez-Perales S
    Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.